Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

The Zacks Rank is a powerful tool which ranks over 4,000 companies in a range from Strong Buy down to Strong Sell. Sounds easy. But, the Rank is a short term recommendation of just 1 to 3 months.

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor. But what's the best way to find the right combination ...

Indivior (INDV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in ...

The Zacks Rank is a short-term stock recommendation of 1 to 3 months which ranks stocks from #1, which is a "Strong Buy", to #5, which is a "Strong Sell".

The latest trading day saw Humacyte, Inc. (HUMA) settling at $2.09, representing a -1.42% change from its previous close.

The Zacks Rank is based on four factors: Agreement, Magnitude, Upside, Surprise. What it is NOT: a bunch of Zacks analysts sitting in a room "downgrading" or "upgrading" a stock.

Since the beginning of 2025, market participants were bullish on the S&P 500’s northbound journey after astonishing rallies ...

Palo Alto belongs to the Zacks Security industry. Another stock from the same industry, Qualys, has gained 1% over the past ...